BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3196369)

  • 1. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients.
    Savi M; Ferraccioli GF; Neri TM; Zanelli P; Dall'Aglio PP; Tincani A; Balestrieri G; Carella G; Cattaneo R
    Arthritis Rheum; 1988 Dec; 31(12):1568-70. PubMed ID: 3196369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens.
    Lulli P; Sebastiani GD; Trabace S; Passiu G; Cappellacci S; Porzio F; Morellini M; Cutrupi F; Galeazzi M
    Clin Exp Rheumatol; 1991; 9(5):475-9. PubMed ID: 1954698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus.
    McHugh NJ; Maddison PJ
    Arthritis Rheum; 1989 Dec; 32(12):1623-4. PubMed ID: 2597215
    [No Abstract]   [Full Text] [Related]  

  • 4. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.
    Hamilton RG; Harley JB; Bias WB; Roebber M; Reichlin M; Hochberg MC; Arnett FC
    Arthritis Rheum; 1988 Apr; 31(4):496-505. PubMed ID: 2451920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus.
    Davies EJ; Hillarby MC; Cooper RG; Hay EM; Green JR; Shah S; Bernstein RM; Holt PJ; Grennan DM
    Br J Rheumatol; 1993 Oct; 32(10):870-5. PubMed ID: 8401996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies: their relationship with HLA-DR antigens in systemic lupus erythematosus.
    Sebastiani GD; Lulli P; Passiu G; Trabace S; Bellucci AM; Morellini M; Galeazzi M
    Br J Rheumatol; 1991 Apr; 30(2):156-7. PubMed ID: 2012952
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated.
    Gammon WR; Heise ER; Burke WA; Fine JD; Woodley DT; Briggaman RA
    J Invest Dermatol; 1988 Sep; 91(3):228-32. PubMed ID: 3137269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.
    Smolen JS; Klippel JH; Penner E; Reichlin M; Steinberg AD; Chused TM; Scherak O; Graninger W; Hartter E; Zielinski CC
    Ann Rheum Dis; 1987 Jun; 46(6):457-62. PubMed ID: 3498447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.
    Harley JB; Sestak AL; Willis LG; Fu SM; Hansen JA; Reichlin M
    Arthritis Rheum; 1989 Jul; 32(7):826-36. PubMed ID: 2787639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
    Ferraccioli G; Savi M
    J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.
    Hochberg MC; Boyd RE; Ahearn JM; Arnett FC; Bias WB; Provost TT; Stevens MB
    Medicine (Baltimore); 1985 Sep; 64(5):285-95. PubMed ID: 2412088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?
    Silva LM; Donadi EA
    Ann Rheum Dis; 1996 Aug; 55(8):544-7. PubMed ID: 8774183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.
    Christian N; Smikle MF; DeCeulaer K; Daniels L; Walravens MJ; Barton EN
    West Indian Med J; 2007 Mar; 56(2):130-3. PubMed ID: 17910142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.
    Brand CA; Rowley MJ; Tait BD; Muirden KD; Whittingham SF
    Ann Rheum Dis; 1992 Feb; 51(2):173-6. PubMed ID: 1550399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.
    Yao Z; Hartung K; Ehrfeld H; Seelig HP; Deicher HG; Brünnler G; Keller E; Albert E
    Rheumatol Int; 1993; 13(4):155-8. PubMed ID: 8310208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE.
    Graham RR; Ortmann W; Rodine P; Espe K; Langefeld C; Lange E; Williams A; Beck S; Kyogoku C; Moser K; Gaffney P; Gregersen PK; Criswell LA; Harley JB; Behrens TW
    Eur J Hum Genet; 2007 Aug; 15(8):823-30. PubMed ID: 17406641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen and autoantibodies association with juvenile systemic lupus erythematosus.
    El Sherbini HM; El Garf AK; El Din Mahmoud SS
    Egypt J Immunol; 2009; 16(2):107-14. PubMed ID: 22059358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
    Harris EN; Gharavi AE; Boey ML; Patel BM; Mackworth-Young CG; Loizou S; Hughes GR
    Lancet; 1983 Nov; 2(8361):1211-4. PubMed ID: 6139567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers.
    Gómez-Reino JJ; Martínez-Laso J; Vicario JL; Paz-Artal E; Aragón A; Martín-Villa JM; De Juan MD; Pérez-Aciego P; Arnaiz-Villena A
    Immunobiology; 1991 Aug; 182(5):465-71. PubMed ID: 1916886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.
    Martín-Villa JM; Martínez-Laso J; Moreno-Pelayo MA; Castro-Panete MJ; Martínez-Quiles N; Alvarez M; de Juan MD; Gómez-Reino JJ; Arnaiz-Villena A
    Ann Rheum Dis; 1998 Apr; 57(4):214-9. PubMed ID: 9709177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.